Docusign is a compelling 'growth at a reasonable price' play, benefiting from a strong Q2 beat, raised guidance, and improving sales execution. The company’s turnaround is evident in rebounding ...
DocuSign (NASDAQ: DOCU) was one of the best-positioned companies to benefit from the pandemic. The company's e-signature platform boomed as industries that had resisted the technology had little ...
While Docusign Inc DOCU seems to have the right strategy to generate double-digit growth in the long term, fiscal 2027 is likely to be "a transition year" for the company, according to BofA Securities ...
As of 5 p.m. ET, DocuSign is now down 16%. As we’ve noted in prior updates, this likely is due to lower-than-expected billings guidance. The punishment to the stock is harsher than we would have ...
We are lowering our fair value estimate for narrow-moat DocuSign to $244 per share, from $290, as we have adjusted our model based on near-term guidance, which reduces our growth forecast over the ...
DocuSign (Nasdaq: DOCU) is mid-transformation from e-signature to Intelligent Agreement Management (IAM). Q1 FY26 delivered 8% revenue growth to $764M and non-GAAP EPS of $0.90, with operating margin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results